Latest / Flash Stock Reports (Video)
ALEC Trades Below Cash After $1.27B Genentech Deal
Alector stock analysis: $1.27B Genentech deal triggers negative EV — buy or sell?
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends
In this deep dive, we break down Alector Inc (ALEC) and its pivotal transition following a landmark $1.27 billion global licensing agreement with Genentech for its Brain Carrier platform. With shares trading near $1.95 and a pro forma cash balance of $223.7 million creating a negative enterprise value, the key…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.